Inventor · disambiguated record
Edwin Aret
Also filed as: ARET EDWIN
15 granted patents·3 pending applications·87 citations·filing 2010–2024
90Inventor score
Files withACERTA PHARMA BV7INTRA CELLULAR THERAPIES INC4KING S COLLEGE LONDON2AICURIS GMBH & CO KG1ARET EDWIN1
Top patents by PatentIndex Score
18 records- 0197US11014925B2Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamideINTRA CELLULAR THERAPIES INC·Filed 2017·Granted May 25, 2021·26 cites·20 claims
- 0296US11440911B2Salts and crystalsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Sep 13, 2022·11 cites·5 claims
- 0396US10654854B2Salts and crystals of ITI-007INTRA CELLULAR THERAPIES INC·Filed 2017·Granted May 19, 2020·32 cites·18 claims
- 0493US9796721B2Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2016·Granted Oct 24, 2017·12 cites·17 claims
- 0585US9637459B2Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agentsAICURIS GMBH & CO KG·Filed 2013·Granted May 2, 2017·4 cites·20 claims
- 0682US2024199622A1Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2023·Application pending·0 cites
- 0778US11820777B2Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2022·Granted Nov 21, 2023·0 cites·27 claims
- 0878US10167291B2Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2017·Granted Jan 1, 2019·1 cites·28 claims
- 0971US11059829B2Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide maleateACERTA PHARMA BV·Filed 2020·Granted Jul 13, 2021·0 cites·42 claims
- 1071US10640509B2Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphomaACERTA PHARMA BV·Filed 2018·Granted May 5, 2020·0 cites·20 claims
- 1171US2022177476A1Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamideACERTA PHARMA BV·Filed 2021·Application pending·0 cites
- 1270US10870644B2Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparationKING S COLLEGE LONDON·Filed 2017·Granted Dec 22, 2020·1 cites·14 claims
- 1367US12384783B2Salts and crystalsINTRA CELLULAR THERAPIES INC·Filed 2022·Granted Aug 12, 2025·0 cites·8 claims
- 1463US11584741B2Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparationKING S COLLEGE LONDON·Filed 2020·Granted Feb 21, 2023·0 cites·13 claims
- 1560US2024343735A1Hydrochloride Salt of Inupadenant, Pharmaceutical Compositions and Methods of Use ThereofiTeos Belgium SA·Filed 2024·Application pending·0 cites
- 1659US11779573B2Crystalline forms of compounds for preventing or treating sensory hair cell deathUNIV WASHINGTON·Filed 2018·Granted Oct 10, 2023·0 cites·16 claims
- 1754US11584735B2Solid forms of a plasma kallikrein inhibitor and salts thereofKALVISTA PHARMACEUTICALS LTD·Filed 2018·Granted Feb 21, 2023·0 cites·15 claims
- 1837US8883780B2Crystal of a benzoxazinone compoundARET EDWIN·Filed 2010·Granted Nov 11, 2014·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Edwin Aret files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →